• Stephen Wing
• 01 Apr, 2021

Many biopharmaceutical and pharmaceutical manufacturers have been planning and investing in various digital technologies to drive business improvements, in order to better serve and meet growing market demands for new and improved drugs and vaccines. The advancement of new technologies and capabilities provides many opportunities to enhance business processes across the enterprise.
Read more...